Results 51 to 60 of about 2,548 (196)
ABSTRACT Background and Aim The demand for hemodialysis (HD) among patients with end‐stage kidney disease (ESKD) is rising globally. A well‐functioning vascular access (VA) is crucial for effective dialysis therapy. This study aims to determine the incidence and risk factors of primary arterio‐venous access (AVA) maturation failure in HD patients ...
Tarek A. Ghonimi +8 more
wiley +1 more source
To the Editor: Primary hyperoxaluria type 1 (PH1) is associated with hepatic overproduction of oxalate. Kidneys gradually become unable to eliminate excess oxalate, leading to systemic oxalosis (SO) with deposits in organs.1 When kidney transplantation ...
Kanaan, Nada +4 more
core +1 more source
ABSTRACT Background Antibody mediated rejection (ABMR) is a major cause of graft loss in kidney transplantation. There are limited treatment options with poor efficacy. Intravenous tocilizumab has been reported to be of benefit in a small number of patients.
Anne M. Durkan +3 more
wiley +1 more source
ABSTRACT Human alanine:glyoxylate aminotransferase (AGT) is a liver peroxisomal enzyme that metabolizes glyoxylate, the oxalate precursor, to glycine. AGT deficiency, due to recessive pathogenic changes in the AGXT gene, results in calcium oxalate accumulation and kidney stones, a condition known as primary hyperoxaluria type 1 (PH1).
Luana Ruta +7 more
wiley +1 more source
Systemic Oxalosis in Infants: Two Cases and Literature Review
The infantile form of primary hyperoxaluria is a very rare disease and often presents as a life-threatening condition because of rapid progression to end-stage renal disease and systemic oxalosis.
Hakan Poyrazoglu +11 more
core +1 more source
Oxalosis and Livedo Reticularis
Oxalosis is a disease caused by the deposition of calcium oxalate in extrarenal tissues, most commonly bone, myocardium, retina, blood vessels, and skin, causing the clinical manifestations of the disease. Involvement of the blood vessels of the skin can give rise to livedo reticularis, acrocyanosis, ulcers, and gangrene.
E, Jorquera-Barquero +3 more
openaire +2 more sources
A Brief History of Inherited Metabolic Diseases: A Personal 60 Years Clinical Flashback
ABSTRACT The concept of IMDs has evolved over a century from rare deficits in amino acid catabolism diagnosed by the accumulation of biochemical markers such as phenylketonuria (PKU) to diseases affecting organelle metabolism, synthesis of complex molecules, and cellular trafficking.
Jean‐Marie Saudubray, Manuel Schiff
wiley +1 more source
Diagnosis of Inherited Metabolic Disease in Older Patients: A Systematic Literature Review
ABSTRACT Inherited metabolic diseases (IMDs) are genetic disorders that disrupt biochemical processes in the human body, due to pathogenic variants in genes encoding enzymes or transporters. While IMDs are mostly diagnosed in infancy or childhood, there is an increasing number of diagnoses in adult patients.
Maria‐Rita Moio +7 more
wiley +1 more source
Systemic Oxalosis in Infants: Two Cases and Literature Review
The infantile form of primary hyperoxaluria is a very rare disease and often presents as a lifethreatening condition because of rapid progression to end-stage renal disease and systemic oxalosis.
Zübeyde GÜNDÜZ +5 more
doaj
In this work, we develop an interactive pipeline for geometry preparation of moving mesh simulations of cardiac hemodynamics. The open source tool is easy to use and can be seamlessly integrated into downstream CFD workflows. ABSTRACT Blood flow within the ventricle can provide important information on the performance of the heart. The determined blood
Jan‐Niklas Thiel +7 more
wiley +1 more source

